I. M. Alekseev

Deep brain stimulation (DBS) in the treatment of bilateral temporal lobe drug-resistant epilepsy: an analysis of 8 cases

Background. Although resection of the epileptogenic zone remains the primary treatment for patients with drug-resistant epilepsy (DRE), it cannot be performed in 30–57 % of cases due to the localization of the epileptogenic zone in functional brain areas or in cases of bilateral brain involvement. In such situations...